| Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B |
| Yuen Man-Fung , Berliba Elina Tudor, Sukeepaisarnjaroen Wattana , Ahn Sang Hoon , Tanwandee Tawesak , Lim Young-Suk , Kim Yoon Jun , Poovorawan Kittiyod , Tangkijvanich Pisit , Schwabe Christian , Eley Timothy , Brown Joanne , Noi Autori , Gane Edward John |
1 University of Hong Kong, Hong Kong,
2 F.C.E. ARENSIA Exploratory Medicine,
3 Khon Kaen University,
4 Yonsei University, Seoul,
5 Mahidol University, Bangkok,
6 Asan Medical Center, Seoul,
7 Seoul National University,
8 Chulalongkorn University,
9 Auckland Clinical Studies, Auckland,
10 Arbutus Biopharma, Warminster,
11 University of Auckland |
| Hepatology Communications |
| Nr. / 2022 / ISSN 2471-254X |
| Disponibil online 12 September, 2023 |
-----------------------------------------------------------------------------------------------------------------------------------
